Minimed Group, Inc. MMED
NASDAQ
| 07/31/2026 | 04/24/2026 | 01/23/2026 | 10/24/2025 | 07/25/2025 | |
|---|---|---|---|---|---|
| Net Income | -318.50M | -337.50M | -324.50M | -215.50M | -216.50M |
| Total Depreciation and Amortization | 158.00M | 156.00M | 155.00M | 153.00M | 148.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 137.00M | 144.00M | 203.00M | 100.00M | 93.00M |
| Change in Net Operating Assets | -176.00M | -254.00M | -72.00M | -118.00M | -42.00M |
| Cash from Operations | -199.50M | -291.50M | -38.50M | -80.50M | -17.50M |
| Capital Expenditure | -207.00M | -219.00M | -220.00M | -217.00M | -203.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.00M | -15.00M | -15.00M | -15.00M | -10.00M |
| Cash from Investing | -212.00M | -234.00M | -235.00M | -232.00M | -213.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 538.00M | 538.00M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -229.00M | -229.00M | -- | -- | -- |
| Other Financing Activities | 299.50M | 501.50M | 273.50M | 309.50M | 207.00M |
| Cash from Financing | 608.50M | 810.50M | 273.50M | 309.50M | 207.00M |
| Foreign Exchange rate Adjustments | 0.00 | 1.00M | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -1.00M | 1.00M | 500.00K |
| Net Change in Cash | 197.00M | 286.00M | -1.00M | -2.00M | -23.00M |